Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Apellis to Submit NDA for Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria

americanpharmaceuticalreviewMay 27, 2020

Tag: Apellis , Pegcetacoplan , NDA

PharmaSources Customer Service